| 122. | Magerl, M., Germenis, A. E., Maas, C., and Maurer, M.: Hereditary angioedema with normal C1 inhibitor: Update on evaluation and treatment. Immunol. Allergy Clin. North Am. 2017: 3; 571-584. IF: 3.69 |
r.122
| 326 | Riedl, M.*+, Farkas, H.*, Bernstein, J. A., Bouillet, L., Sheridan, W. P., and Maurer, M.: Evaluation of avoralstat, an oral kallikrein inhibitor, in a phase 3 hereditary angioedema prophylaxis trial: the OPuS-2 study. Allergy 2018: 73; 1871-1880. IF: 6.77 |
| 309 | Maurer, M.*+, Magerl, M.*, Ansotegui, I., Aygören-Pürsün, E., Betschel, S., Bork, K., Bowen, T., Balle Boysen, H., Farkas, H., Grumach, A. S., Hide, M., Katelaris, C., Lockey, R., Longhurst, H., Lumry, W., Martinez-Saguer, I., Moldovan, D., Nast, A., Pawankar, R., Potter, P., Riedl, M., Ritchie, B., Rosenwasser, L., Sánchez-Borges, M., Zhi, X., Zuraw, B., and Craig, T.: The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update. Allergy 2018: 73; 1575-1596. IF: 6.77 |
| 308 | Maurer, M.*+, Magerl, M.*, Ansotegui, I., Aygören-Pürsün, E., Betschel, S., Bork, K., Bowen, T., Balle Boysen, H., Farkas, H., Grumach, A., Hide, M., Katelaris, C., Lockey, R., Longhurst, H., Lumry, W., Martinez-Saguer, I., Moldovan, D., Nast, A., Pawankar, R., Potter, P., Riedl, M., Ritchie, B., Rosenwasser, L., Sánchez-Borges, M., Zhi, X., Zuraw, B., and Craig, T.: The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update. World Allergy Organ. J. 2018: 11; 5. IF: 3.68 |
o.308
| 167 | Zanichelli, A.+, Magerl, M., Longhurst, H., Fabien, V., and Maurer, M.: Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe. Allergy Asthma Clin. Immunol. 2013: 9; 29. IF: N/A |